• H. Dunbar Hoskins Jr., MDThe H. Dunbar Hoskins Jr., M.D. Center for Quality Eye Care was established as a quality of care and health policy research center that advances the accessibility to and appropriateness of eye care services. The work of the Hoskins Center will help ensure that patients continue to receive high quality, evidence-based eye care within a tightening economic environment that demands increased value for services provided.

  • from AAO OTAC Oculoplastics/Orbit Panel, Hoskins Center for Quality Eye Care
    Orbital radiation appears to modify the active phase of thyroid eye disease. It may help prevent and treat compressive optic neuropathy, improve motility restriction, and decrease clinical activity in thyroid eye disease.
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    The current literature does not support the use of topical Arnica montana, vitamin K oxide, R. tomentosum, or Melilotus extract for reducing ecchymosis after oculofacial surgery or pulsed dye laser surgery.
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    Despite reports of visual improvement with corticosteroids, optic canal decompression, and medical therapy for indirect TON, the weight of published evidence does not demonstrate a consistent benefit for any of these interventions. In summary, no consensus exists from studie…
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    Although methodological limitations and potential conflicts of interest in some studies raised concern, the existing body of literature demonstrates improvements in the signs and symptoms of MGD after IPL therapy.
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    Sentinel lymph node biopsy is a promising procedure in patients with eyelid and conjunctival malignancy, and it is useful in identifying sentinel lymph nodes. However, at present, insufficient evidence exists showing that SLNB improves patient outcomes and survival. Recognit…
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    The current literature suggests that BADM grafts represent an implantation option for lower eyelid retraction repair. Short-term results are favorable, and the materials used may fill an important gap in care for patients for whom no acceptable alternatives exist.
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    The literature indicates that balloon dacryoplasty is a safe, effective procedure to address congenital nasolacrimal duct obstruction that persists after standard probings. The outcomes of this intervention are similar to those of lacrimal stenting.
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    Botox, Meditoxin, and Xeomin are effective for the treatment of BEB. Meditoxin and Botox have equivalent effectiveness and incidence of adverse events for BEB and HFS. Higher doses of Botox and Dysport result in more adverse events.
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    Orbital implants resulted in excellent motility after enucleation surgery. Major complications were rare, and infection was uncommon. Data were inconclusive on motility and comparisons of porous and nonporous implants.
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    Evidence demonstrates that local control, disease-free survival and overall survival are good with radiation treatment for MALT lymphomas. Treatment results of non-MALT lymphomas using radiotherapy were not as favorable as the MALT lymphomas results.
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    Evidence-based review on the effectiveness of oral antibiotics in the management of ocular surface disease that arises from disorders of the meibomian glands and to assess the efficacy of oral antibiotics in the management of this common ocular disease
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    Evidence-based review of the literature to determine functional indications for upper eyelid ptosis and blepharoplasty surgery
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics Panel, Hoskins Center for Quality Eye Care
    Reviews the evidence for safety and effectiveness of botulinum toxin for glabellar, frontal, and lateral canthal rhytids (wrinkles) and the potential functional complications of botulinum toxin cosmetic rejuvenation of the periocular and facial region.
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics Panel, Hoskins Center for Quality Eye Care
    Reviews the indications, techniques, and complications of endonasal DCR and compares the evidence for effectiveness to external DCR
    Ophthalmic Technology Assessment
    from OTAC Oculoplastics Panel, Hoskins Center for Quality Eye Care
    Reviews the techniques, risks, and complications of laser blepharoplasty and skin resurfacing.
    Ophthalmic Technology Assessment